Progress of surgery combined with radiotherapy for primary hepatocellular carcinoma
10.3760/cma.j.issn.0254-5098.2019.07.014
- VernacularTitle:原发性肝细胞肝癌手术联合放疗的进展
- Author:
Yanling WU
1
;
Qinfu FENG
Author Information
1. 国家癌症中心/国家肿瘤临床研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科
- Keywords:
Hepatocellular carcinoma;
Surgery;
Radiotherapy
- From:
Chinese Journal of Radiological Medicine and Protection
2019;39(7):554-557
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma ( HCC) is a common malignant tumor that seriously endangers human health. Surgical resection is the main radical treatment for early and mid-stage HCC, but the recurrence rate is high. At present, there is no effectively and universally accepted adjuvant therapy to reduce the high postoperative recurrence rate. With the development of precise radiotherapy technology, the safe and higher radiation doses can be used in tumors locally. Therefore, radiotherapy is increasingly applied to the treatment of HCC. At present, the position of radiotherapy in the treatment of advanced HCC has become more and more clear. However, the position in the adjuvant treatment of HCC has not been clear. This article will review the research of radiotherapy as adjuvant therapy for surgery in HCC, so as to provide reference for the application of clinical adjuvant therapy for HCC.
